SINTX TechnologiesSINT -0.79%27 Cyclically Adjusted PB Ratio is 0.00 as of Jul. 06, 2026. GuruFocus rates SINT with a GF Score™ of 27/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 525 Medical Devices & Instruments companies, SINTX Technologies ranks worse than 190476% on this metric.
The historical rank and industry rank for SINTX Technologies's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, SINTX Technologies's highest Cyclically Adjusted PB Ratio was 0.58. The lowest was 0.01. And the median was 0.03.
SINT's Cyclically Adjusted PB Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.8 * Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
SINTX Technologies's adjusted book value per share data for the three months ended in Mar. 2026 was $0.219. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $10,031.49 for the trailing ten years ended in Mar. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
SINTX Technologies (NAS:SINT) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
SINTX Technologies Cyclically Adjusted PB Ratio Related Terms
SINTX Technologies Cyclically Adjusted PB Ratio Historical Data
* Premium members only.
The historical data trend for SINTX Technologies's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SINTX Technologies Cyclically Adjusted PB Ratio Chart
SINT vs ALRTF, CODX, PMI: Cyclically Adjusted PB Ratio Comparison
For the Medical Devices subindustry, SINTX Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SINTX Technologies Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where SINTX Technologies's Cyclically Adjusted PB Ratio falls into.
SINTX Technologies Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
SINTX Technologies's Cyclically Adjusted PB Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 0.00 mean?
SINTX Technologies (SINT) has a Cyclically Adjusted PB Ratio of 0.00 as of Jul. 06, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on SINTX Technologies and its competitors. Over the past decade, SINTX Technologies' Cyclically Adjusted PB Ratio has ranged from 0.01 to 0.58. According to the industry distribution chart, SINTX Technologies ranks #999999 out of 525 companies in the Medical Devices & Instruments industry.
Is SINTX Technologies' Cyclically Adjusted PB Ratio too high?
SINTX Technologies' current Cyclically Adjusted PB Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.58. Based on the distribution chart, SINTX Technologies ranks #999999 out of 525 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SINTX Technologies has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SINTX Technologies' Cyclically Adjusted PB Ratio compare to ALRTF and CODX?
According to the Medical Devices & Instruments industry distribution chart, SINTX Technologies ranks #999999 out of 525 companies for Cyclically Adjusted PB Ratio. This places SINTX Technologies in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.80. Historically, SINTX Technologies' own Cyclically Adjusted PB Ratio has ranged from 0.01 to 0.58 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Medical Devices & Instruments company?
The median Cyclically Adjusted PB Ratio among Medical Devices & Instruments companies is 1.80, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on SINTX Technologies and its competitors. For the Medical Devices & Instruments industry, the median Cyclically Adjusted PB Ratio is 1.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SINTX Technologies's current Cyclically Adjusted PB Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SINTX Technologies stock overvalued right now?
Based on GuruFocus' analysis, SINTX Technologies (SINT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $1.89 — trading 1156.7% above its estimated fair value. The current Cyclically Adjusted PB Ratio is 0.00. SINTX Technologies' overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For SINTX Technologies (SINT), the current Cyclically Adjusted PB Ratio is 0.00 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SINTX Technologies (SINT) Overvalued in 2026?
Based on GuruFocus' analysis, SINTX Technologies stock appears to be overvalued.
The current stock price of $1.89 is trading 1156.7% above its estimated GF Value™ of $0.15.
GuruFocus considers SINTX Technologies to be Significantly Overvalued.
Key valuation signals for SINT:
Cyclically Adjusted PB Ratio: 0.00
GF Value™: $0.15 vs. price of $1.89 (1156.7% above fair value)
No single metric tells the full story. See the SINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
27GF Score
Get the complete analysis for SINT
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SINT has been successfully added to your 
